AB
Anavatos Bio Inc.
SEC filingBiotechnology · Seattle, WA
Amount raised$393Ksold at filing
Total offeringNot stated
Investors in the raise4count reported to the SEC
FiledJul 20, 2026first sale Apr 27, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Leah KleinExecutive Officer
Executive officers, directors and promoters as listed on the Form D.